Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Senti Biosciences Holdings, Inc. reported first quarter 2026 financial results highlighting a positive FDA meeting that supports a single-arm pivotal trial for SENTI-202 targeting relapsed/refractory AML. The company secured a strategic financing agreement for up to $40 million and made operational efficiencies leading to reduced net loss and cash …
Stabilis Solutions CFO Andrew L. Puhala recently acquired a block of common stock on May 12, 2026. This transaction occurs amidst mixed company performance, as the firm reported an earnings per share (EPS) loss and lower-than-expected revenue in Q1 2026. However, internal valuation metrics suggest the company may be undervalued.
SharonAI Holdings (NASDAQ: SHAZ) announced a cloud infrastructure agreement valued at roughly $950 million over five years with a global technology company, prompting an 8.8% rise in premarket trading. The work will roll out across multiple NEXTDC data centers in Australia and will use the Vast Data AI Operating System, with revenue projected to co…
U.S. stock futures were trading higher early Thursday as investor attention remained focused on persistent enthusiasm around artificial intelligence and on news emerging from a widely anticipated summit between U.S. and Chinese leaders. By 07:13 ET (11:13 GMT) the Dow futures were up 396 points (0.8%), S&P 500 futures rose 25 points (0.3%), and Nas…
AIM ImmunoTech released a virtual investor segment featuring expert insights and positive interim results for Ampligen in treating late-stage pancreatic cancer. The data from the Named Patient Program and ongoing Phase 2 trial suggest improvements in progression-free and overall survival, underlining Ampligen's potential as an immunotherapeutic opt…
Senti Biosciences reported a successful FDA RMAT meeting focusing on the registrational clinical and CMC strategy for SENTI-202, an off-the-shelf CAR-NK cell therapy for relapsed/refractory AML. The company revealed that selecting Donor X phenotype for manufacturing improves efficacy, showing a 50% composite complete remission rate, and plans a sin…
OppFi (OPFI) is a specialty-finance fintech that has shown strong profitability and free cash flow while leveraging AI to scale originations. The stock pulled back to $8.87 after a recent dip; we view this as a buying opportunity with a mid-term target of $12 and a disciplined stop at $7.25. Valuation metrics (P/E ~11-12, EV/EBITDA ~4.9) leave room…
Shares of Take-Two Interactive rose after social posts circulated screenshots purporting to show a Best Buy email announcing a Grand Theft Auto VI pre-order window beginning May 18. The rumor-driven move pushed the stock to its strongest level since January, but neither Take-Two nor Rockstar Games have confirmed the report and major outlets could n…
GRI Bio, Inc. announced positive Phase 2a clinical trial results for GRI-0621 in idiopathic pulmonary fibrosis (IPF), demonstrating significant reductions in cough, dyspnea, and treatment-related diarrhea, along with improved lung function and no serious adverse events. The company is progressing its GRI-0803 program for autoimmune diseases and rep…
Biogen Inc. has completed the acquisition of Apellis Pharmaceuticals, adding two commercialized complement-targeting therapies, EMPAVELI® and SYFOVRE®, which generated $689 million in 2025 revenue. This acquisition accelerates Biogen's expansion into nephrology and is expected to be accretive to non-GAAP diluted EPS in 2027, supporting stronger gro…
Apple’s core cash engine—iPhone plus Services—still generates extraordinary free cash flow ($129.2B) and returns on equity (115%). Valuation is rich at ~35x EPS, but a combination of an accelerating AI upgrade cycle, services monetization, and a relatively light balance-sheet leverage (debt/equity 0.8) supports upside. I outline a long trade with a…
Biogen said it will advance diranersen, an experimental tau-directed therapy for early Alzheimer’s disease, into late-stage development after mid-stage results from 416 participants showed reductions in brain tau and evidence of slower cognitive decline. The drug did not achieve the study's primary endpoint, but biomarker and clinical signals gave …
BOXABL Inc. said the Securities and Exchange Commission has declared effective its Form S-4 registration statement for a proposed merger with FG Merger II Corp., advancing the company’s plan to become a publicly listed entity. Both companies will hold shareholder votes on June 9, 2026. If the merger closes, the combined business is expected to trad…
Neuronetics announces a strategic collaboration with ANT Neuro to integrate ANT Neuro's visor2 neuronavigation system with the NeuroStar Advanced Therapy System, enhancing real-time spatial tracking and 3D visualization for more precise and personalized transcranial magnetic stimulation (TMS) treatments. This partnership aims to improve treatment c…
20/20 BioLabs, a Nasdaq-listed company specializing in AI-powered blood tests for early detection of cancer and chronic diseases, announced its CEO's participation in the Sidoti Micro-Cap Virtual Conference on May 20, 2026. The company will discuss recent quarterly results, partnership and licensing activities, and plans to scale its OneTest platfo…
Helport AI Limited has launched its next-generation AI-powered corporate website, demonstrating its flagship HyprX Expert Replication Engine. This new platform transforms traditional static websites into interactive AI labor environments, replicating expert human capabilities to enhance real-time customer interactions and enterprise workflows. Help…
Republic Technologies Inc., listed on the Canadian Securities Exchange, will announce that it has entered into a worldwide, non-exclusive software licensing agreement with the Sign Foundation. The license covers Sign's S.I.G.N. architecture - including Sign Protocol and Sign App - and is intended to support Republic's work on attestation and valida…
Robo.ai Inc. (NASDAQ:AIIO) saw its shares rise 67% in premarket trading after its subsidiary Neurovia AI formally released NeuroStream, a platform the company says dramatically reduces visual data file sizes using a bitmap vectorization algorithm. Company testing reported a 5.5GB 4K 60fps video compressed to 278MB, and NeuroStream is intended for d…
Upstart Holdings CEO Paul Gu acquired 50,000 shares of the company's common stock on May 13, 2026, for a total value of $1,375,000. This transaction occurred as Upstart trades near its 52-week low and follows mixed first-quarter financial results. The recent insider activity, alongside strategic announcements such as a partnership with USF Credit U…
Rush Street Interactive delivered a blowout Q1 with $370M revenue and materially higher profitability. The market's response and upgraded 2026 guidance create a tradeable long opportunity: enter near $27.00, protect with a $24.00 stop, and target $34.00 over a 180-trading-day hold while watching user growth and repurchase activity.
Genesco is a cash-generative footwear and apparel retailer with a clear path to margin repair as digital investments mature and promotional intensity eases. Shares trade at an attractive multiple relative to cash flow and book value, and the current technical base provides a reasonable entry for a mid-term swing aiming to the 52-week high if execut…
Multiple Wall Street firms downgraded Wix.com following a weaker-than-expected first-quarter report that highlighted growing competitive pressure from AI-powered coding tools and rising costs tied to the company’s Base44 acquisition. The stock fell sharply, analysts trimmed earnings and cash flow forecasts, and management lowered its free cash flow…
BitFuFu Inc., a Nasdaq-listed Bitcoin mining company, announced April 2026 production metrics showing a decline in Bitcoin output primarily caused by a power outage at its Ethiopia facility and a strategic reduction in third-party hashrate procurement. Despite these setbacks, the company maintained steady self-owned hashrate, increased its Bitcoin …
Waldencast plc's Obagi Medical has partnered with Next Health to create "The Skin Recharge Station," a limited-time pop-up tour combining advanced skincare with wellness, introducing consumers to NAD+ science and Obagi's NU-GEN Cellular Renewal Serum, enhancing brand engagement and promoting healthy aging through innovative products and experiences…
Fiserv held its 2026 Investor Day presenting its One Fiserv action plan emphasizing disciplined strategy execution. The company projects adjusted and organic revenue growth of 1% to 3% for 2026 and forecasts medium-term compounded annual growth rates of 4% to 6%, with operating margins surpassing 37% by 2029. Fiserv expects adjusted earnings per sh…
